Stauder J, Hertle F H, Quarz W
Z Erkr Atmungsorgane. 1981;157(3):256-61.
The inhalation therapy assisted by IPPB has been well established as the standard programme of intensive care units for many years. The use of inhalation by assisted ventilation at home is difficult because 4-6 applications daily are necessary to reach a suitable effect. This form of treatment has to perform at patient's home and an apparatus has to put ready for these patients. Our investigations pursued the aim to prove the effectiveness by means of objective parameters. The home treatment was carried on 32 patients with respiratory insufficiency over a period of and average of 51 months. This group was controlled after 2 years. Lung function tests and blood gas analysis showed a tiny but not significant deterioration. We were able to demonstrate that the hospitalization rate can be lowered, the bronchitis symptoms and respiratory decompensation reduced, and well-being significantly improved. This results have led to the conclusion that this treatment obviously influence the follow-up of the respiratory insufficiency.
多年来，IPPB辅助的吸入疗法一直是重症监护病房的标准治疗方案。在家中使用辅助通气进行吸入治疗很困难，因为每天需要进行4至6次才能达到合适的效果。这种治疗形式必须在患者家中进行，并且必须为这些患者准备好设备。我们的研究旨在通过客观参数证明其有效性。对32例呼吸功能不全患者进行了平均51个月的家庭治疗。该组在2年后进行了对照。肺功能测试和血气分析显示有轻微但不显著的恶化。我们能够证明住院率可以降低，支气管炎症状和呼吸失代偿减轻，幸福感显著提高。这些结果得出的结论是，这种治疗显然会影响呼吸功能不全的后续情况。
